Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
66.36
-1.17 (-1.73%)
At close: Nov 10, 2026, 4:00 PM EST
66.58
+0.22 (0.33%)
After-hours: Nov 10, 2026, 7:30 PM EST
Vaxcyte Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Vaxcyte stock has a consensus rating of "Strong Buy" and an average price target of $117.2. The average 1-year stock price forecast is 76.61% higher than the current stock price, while the lowest is $75 (+13.02%) and the highest is $163 (+145.63%).
Price Target: $117.2 (+76.61%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vaxcyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 5, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $102 | Buy | Maintains | $102 | +53.71% | Nov 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $75 | Buy | Maintains | $75 | +13.02% | Nov 5, 2026 |
| BTIG | BTIG | Buy Maintains $89 | Buy | Maintains | $89 | +34.12% | Nov 5, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $125 | Buy | Reiterates | $125 | +88.37% | Oct 19, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
112.04M
EPS This Year
-8.29
from -5.63
EPS Next Year
-7.15
from -8.29
EPS and Forward PE are based on non-GAAP adjusted numbers.